Stockscreener 앱 받기
53.07
0.72%
0.37
시간 외 거래:
53.07
전일 마감가:
$52.70
열려 있는:
$52.77
하루 거래량:
2.49M
Relative Volume:
0.98
시가총액:
$9.87B
수익:
$2.69B
순이익/손실:
$-214.04M
주가수익비율:
-33.47
EPS:
-1.5857
순현금흐름:
$98.43M
1주 성능:
+4.22%
1개월 성능:
-23.60%
6개월 성능:
-0.82%
1년 성능:
-18.51%
1일 변동 폭
$52.17
$54.06
1주일 범위
$48.72
$54.55
52주 변동 폭
$40.62
$79.62
이그젝트 사이 Stock (EXAS) Company Profile
명칭
Exact Sciences Corp
전화
608-284-5700
주소
5505 ENDEAVOR LANE, MADISON, WI
EXAS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| EXAS | 53.07 | 9.87B | 2.69B | -214.04M | 98.43M | -1.5857 |
| TMO | 516.10 | 196.16B | 42.37B | 6.14B | 7.78B | 15.26 |
| DHR | 235.09 | 167.14B | 23.74B | 3.89B | 4.98B | 7.93 |
| A | 132.05 | 37.71B | 6.50B | 1.41B | 1.42B | 3.82 |
| IQV | 197.53 | 35.48B | 15.32B | 1.41B | 1.96B | 5.95 |
| IDXX | 418.55 | 33.75B | 3.84B | 866.24M | 792.60M | 9.80 |
이그젝트 사이 Stock (EXAS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-06-27 | 개시 | Scotiabank | Sector Outperform |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-01-02 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-10-10 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-09-28 | 개시 | Bernstein | Outperform |
| 2023-08-02 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2023-05-10 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2023-05-05 | 개시 | UBS | Neutral |
| 2023-03-09 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-02-10 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2023-01-18 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2022-10-19 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-06-03 | 개시 | Piper Sandler | Neutral |
| 2021-11-03 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2021-07-29 | 재확인 | BTIG Research | Buy |
| 2021-07-29 | 재확인 | Canaccord Genuity | Buy |
| 2021-07-29 | 재확인 | Oppenheimer | Outperform |
| 2021-07-29 | 재확인 | Stifel | Buy |
| 2021-06-15 | 개시 | Raymond James | Strong Buy |
| 2021-06-03 | 개시 | Goldman | Buy |
| 2021-05-25 | 개시 | Wells Fargo | Equal Weight |
| 2021-01-28 | 개시 | Truist | Buy |
| 2020-10-29 | 다운그레이드 | UBS | Buy → Neutral |
| 2020-10-28 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-10-08 | 재개 | BTIG Research | Buy |
| 2020-04-02 | 개시 | Evercore ISI | Outperform |
| 2020-01-10 | 재개 | BTIG Research | Buy |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-12-13 | 개시 | Dougherty & Company | Buy |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-10-17 | 재확인 | BofA/Merrill | Buy |
| 2019-10-01 | 재개 | Craig Hallum | Buy |
| 2019-09-26 | 개시 | Oppenheimer | Outperform |
| 2019-02-26 | 업그레이드 | Goldman | Neutral → Buy |
| 2018-10-09 | 개시 | UBS | Buy |
| 2018-09-05 | 재개 | The Benchmark Company | Hold |
| 2018-08-13 | 재확인 | Canaccord Genuity | Buy |
| 2018-04-03 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2018-01-29 | 개시 | Goldman | Neutral |
| 2018-01-08 | 재확인 | The Benchmark Company | Buy |
| 2017-11-13 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2017-11-01 | 다운그레이드 | BTIG Research | Buy → Neutral |
모두보기
이그젝트 사이 주식(EXAS)의 최신 뉴스
Swiss National Bank Increases Holdings in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Madison-based Exact Sciences reports Q3 results short of analysts’ expectations - Chippewa Herald
EULAV Asset Management Has $20.78 Million Position in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Exact Sciences Corporation (EXAS): Among the Best Genomics Stocks to Buy Right Now - Insider Monkey
Exact Sciences Co. (NASDAQ:EXAS) Sees Large Drop in Short Interest - MarketBeat
Exact Sciences Co. (NASDAQ:EXAS) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Exact Sciences Partners with Actor and TV Personality Carlos Ponce to Increase Awareness of Colon Cancer Screening Among Hispanic Community - Business Wire
EXAS Stock Set to Benefit From Favorable Study Data Backing MCED Test - Yahoo Finance
Chairman of The Board & CEO of Exact Sciences Picks Up 2.7% More Stock - Yahoo Finance
Exact Sciences Co. (NASDAQ:EXAS) Shares Acquired by Simplify Asset Management Inc. - MarketBeat
Exact Sciences showcases early cancer detection test data at AACR meeting - Clinical Trials Arena
Exact Sciences Co. (NASDAQ:EXAS) Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Exact Sciences Unveils Data Showing Promise of Multi-Cancer Early Detection at AACR Special Conference on Liquid Biopsy - BioSpace
Capital World Investors Reduces Stake in Exact Sciences Corp - GuruFocus.com
Exact Sciences CEO Kevin Conroy buys $1 million in stock By Investing.com - Investing.com Nigeria
Exact Sciences reports progress in early cancer detection - Investing.com
Exact Sciences reports progress in early cancer detection By Investing.com - Investing.com UK
Exact Sciences CEO Kevin Conroy buys $1 million in stock - Investing.com India
Exact Sciences' Cancer Test Shows 28% Better Early Detection, Could Cut Deaths by 17% | EXAS Stock News - StockTitan
Los Angeles Capital Management LLC Takes Position in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Exact Sciences Corp (EXAS) Stock Price Down 6.11% on Nov 12 - GuruFocus.com
Exact Sciences Co. (NASDAQ:EXAS) Shares Purchased by WCM Investment Management LLC - MarketBeat
Exact Sciences Corporation (EXAS) Rebounded from the Previous Quarter - Yahoo Finance
15,260 Shares in Exact Sciences Co. (NASDAQ:EXAS) Acquired by Lisanti Capital Growth LLC - MarketBeat
Exact Sciences: Cancer Detection Stalwart's Bad Quarter Resets Its Overgrown Market Cap. - Seeking Alpha
Exact Sciences Co. (NASDAQ:EXAS) Shares Sold by Principal Financial Group Inc. - MarketBeat
Wellington Management Group LLP Reduces Stake in Exact Sciences Corp - GuruFocus.com
ARK Investment Management LLC Sells 117,043 Shares of Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Analysts Set Expectations for Exact Sciences Q4 Earnings - MarketBeat
Exact Sciences’ forecast cut shocks analysts - Yahoo Finance
Exact Sciences Corporation (NASDAQ:EXAS) Q3 2024 Earnings Call Transcript - Insider Monkey
Van ECK Associates Corp Sells 17,484 Shares of Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Exact Sciences Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Exact Sciences: Q3 Sell-Off May Be Unjustified But Long-Term Outlook A Concern (EXAS) - Seeking Alpha
Cologuard Maker Exact Sciences Slashes Outlook as Losses Mount - Yahoo Finance
Piper Sandler maintains Overweight rating on Exact Sciences shares - Investing.com
Exact Sciences stock target cut by Benchmark, retains Buy rating - Investing.com
Exact Sciences (NASDAQ:EXAS) Shares Gap Down on Disappointing Earnings - MarketBeat
Colorectal Cancer Diagnostic Focused Exact Sciences Stock Plunges On Weak Annual Guidance, Analyst Sees Compelling Long-Term Entry Point - Yahoo Finance
Exact Sciences (NASDAQ:EXAS) Given New $65.00 Price Target at Benchmark - MarketBeat
Craig Hallum Issues Pessimistic Forecast for Exact Sciences (NASDAQ:EXAS) Stock Price - MarketBeat
Exact Sciences Stock Down On Q3 Earnings & Revenue Miss, '24 View Cut - Barchart
Exact Sciences (NASDAQ:EXAS) Price Target Lowered to $67.00 at Robert W. Baird - MarketBeat
Exact Sciences stock target cut, outperform rating on revenue outlook - Investing.com
Exact Sciences Stock Down on Q3 Earnings & Revenue Miss, '24 View Cut - Yahoo Finance
Exact Sciences Collapses On 'Alarming' Guidance Cut. Is The Growth Story Broken? - Yahoo! Voices
Exact Sciences Corp (EXAS) Q3 2024 Earnings Call Highlights: Str - GuruFocus.com
Exact Sciences Corp (EXAS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... - Yahoo Finance
Decoding Exact Sciences Corp (EXAS): A Strategic SWOT Insight - GuruFocus.com
Exact Sciences Reports Strong Q3 Performance and Pipeline Advances - TipRanks
Exact Sciences Announces Third-Quarter 2024 Results - BioSpace
이그젝트 사이 (EXAS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.91%
0.01%
자본화:
|
볼륨(24시간):